By Dennis Thompson HealthDay ReporterFRIDAY, Feb. 27, 2026 (HealthDay News) — An experimental blood test can predict whether ...

18F-DOPA PET-guided proton beam therapy improved overall survival in older glioblastoma patients, with a median OS of 13.1 months and no grade 4 adverse events. The hypofractionated regimen, completed ...

New York: During the early years of the COVID-19 pandemic, experts worried that disruptions to cancer diagnosis and treatment would cost lives. A new study suggests they were right. The federally ...

Corticosteroids may cut short-term mortality in patients with severe pneumonia or acute respiratory distress syndrome (ARDS), but evidence backing a long-term mortality benefit remains murky, ...